Palvella Therapeutics's top three insider shareholders as of March 23, 2026 are Capital Management, Llc Adar1 (TenPercentOwner, 15.07K shares), Tim Demuth (Chief Medical Officer, 6.00K shares), Shane Olwill (Chief Development Officer, 4.64K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Capital Management, Llc Adar1 | 0 | 15,067 | 12 Aug, 2024 | |
| Tim Demuth | Chief Medical Officer | 6,000 | 0 | 16 May, 2022 |
| Shane Olwill | Chief Development Officer | 4,638 | 0 | 01 Sep, 2021 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 18 Mar, 2026 | Kathleen Goin | Common Stock | A | 2,154 | $7.14 | 2,154 | D | M |
| 18 Mar, 2026 | Kathleen Goin | Common Stock | A | 2,148 | $9.08 | 4,302 | D | M |
| 18 Mar, 2026 | Kathleen Goin | Common Stock | D | 2,268 | $117.56 | 2,034 | D | S |
| 18 Mar, 2026 | Kathleen Goin | Common Stock | D | 1,730 | $118.37 | 304 | D | S |
| 18 Mar, 2026 | Kathleen Goin | Common Stock | D | 304 | $119.08 | 0 | D | S |
| 18 Mar, 2026 | Kathleen Goin | Stock Option (Right to Buy) | D | 2,154 | $0.00 | 15,089 | D | M |
| 18 Mar, 2026 | Kathleen Goin | Stock Option (Right to Buy) | D | 2,148 | $0.00 | 15,036 | D | M |
| 18 Feb, 2026 | Kathleen Goin | Common Stock | A | 2,154 | $7.14 | 2,154 | D | M |
| 18 Feb, 2026 | Kathleen Goin | Common Stock | A | 2,154 | $7.14 | 2,154 | D | M |
| 18 Feb, 2026 | Kathleen Goin | Common Stock | A | 2,148 | $9.08 | 4,302 | D | M |
| 18 Feb, 2026 | Kathleen Goin | Common Stock | A | 2,148 | $9.08 | 4,302 | D | M |
| 18 Feb, 2026 | Kathleen Goin | Common Stock | D | 3,026 | $79.16 | 1,276 | D | S |
| 18 Feb, 2026 | Kathleen Goin | Common Stock | D | 3,026 | $79.16 | 1,276 | D | S |
| 18 Feb, 2026 | Kathleen Goin | Common Stock | D | 1,276 | $79.97 | 0 | D | S |
| 18 Feb, 2026 | Kathleen Goin | Common Stock | D | 1,276 | $79.97 | 0 | D | S |
| 18 Feb, 2026 | Kathleen Goin | Stock Option (Right to Buy) | D | 2,154 | $0.00 | 17,243 | D | M |
| 18 Feb, 2026 | Kathleen Goin | Stock Option (Right to Buy) | D | 2,154 | $0.00 | 17,243 | D | M |
| 18 Feb, 2026 | Kathleen Goin | Stock Option (Right to Buy) | D | 2,148 | $0.00 | 17,184 | D | M |
| 18 Feb, 2026 | Kathleen Goin | Stock Option (Right to Buy) | D | 2,148 | $0.00 | 17,184 | D | M |
| 05 Feb, 2026 | Jeffrey S Martini | Stock Option (Right to Buy) | A | 64,318 | $0.00 | 64,318 | D | A |